432 filings
Page 4 of 22
6-K
58i6n1z 8gbixhgnr6w
24 Jul 19
Update on its Oxycodone ER New Drug Application
5:13pm
6-K
6d7ow9xtlmp t9
10 Jul 19
Primary Document
5:08pm
6-K
birft7ruyn
8 Jul 19
Primary Document
5:18pm
25-NSE
igr6a
3 Jun 19
Exchange delisting
9:59am
6-K
8n7jn5xrz g48es
30 May 19
Intellipharmaceutics Announces Receipt of Cannabis Drug License from Health Canada
8:51am
6-K
e5iqmezxs 6px
29 May 19
Intellipharmaceutics Reports Director Election Results
5:07pm
424B3
eqb2sq yhcify
29 May 19
Prospectus supplement
3:18pm
424B3
1kx2rgk4os62q46o6boq
29 May 19
Prospectus supplement
3:13pm
6-K
73gxuegitl 5cw
29 May 19
Intellipharmaceutics to present at the 9th Annual LD Micro Invitational
9:38am
6-K
noyyx6c92lzhljpi
28 May 19
Annual & Special Meeting of Shareholders
4:41pm
424B3
ighqdfditngfo9 gc77l
10 May 19
Prospectus supplement
3:26pm
424B3
a1i5w3l
10 May 19
Prospectus supplement
3:18pm
6-K
0tplvoltga
10 May 19
Primary Document
1:07pm
6-K
rdp292na wcqhdvnz4u3
8 May 19
Intellipharmaceutics Closes US$1.05 Million Convertible Debenture Financing
12:00am
424B3
jtgkxz6 p8sctlaggm
26 Apr 19
Prospectus supplement
12:13pm
424B3
b8dvs52 elj6zezcsc
26 Apr 19
Prospectus supplement
12:10pm
6-K
e2aamstc
26 Apr 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
12:00am
424B3
4o48rsmnyrc8t3 8rz9
17 Apr 19
Prospectus supplement
10:49am
424B3
5khvrd7aezwxlnhni
17 Apr 19
Prospectus supplement
10:46am
6-K
qpfo3sc52 t1heto
15 Apr 19
Primary Document
4:25pm